Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Conference Call December 11, 2024 4:30 PM ET
Company Participants
Ronnie Morris – Chief Executive Officer
David Miller – Chief Financial Officer
Operator
Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. You may begin.
Ronnie Morris
Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.
Before I begin, I will remind you that we will be making forward-looking statements during today’s call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available on our Forms 10-Q and Form 10-K. A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release. Q2 was another strong quarter for Champions Oncology. The positive momentum that began in the fourth quarter of 2024 continued through the first half of this year with another quarter of positive financial results.
Our core services business saw a sustained growth driven by our industry-leading PDX bank, our precisely characterized multi-omic data, operational improvement and strong customer relationships. Over the past year, we have focused on strengthening our teams and refining processes, resulting in enhanced quality, greater efficiency and scalability. The expanding R&D budgets in the sector have further boosted our confidence, leading to increased bookings and reduce cancellations, reinforcing our strong long-term growth outlook.
